Preliminary report May 1, 1998 - April 30, 1999

Preliminary report May 1, 1998 - April 30, 1999 · The pretax loss was SEK 140 M (252). · Net sales for comparable units were SEK 1,884 M (1,555), an increase of 21% · A new product program for radiation oncology, Elekta Precise Treatment System, was introduced. · A new generation of the Leksell Gamma Knife, Model C, was launched. For further information, please contact: Lars Jonsteg, Vice President, Corporate Relations, Elekta AB (publ), Tel: +46 8-587 254 82. ------------------------------------------------------------ This information was brought to you by Waymaker The following files are available for download: The full report

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,700 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm.


Documents & Links